| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRH | Ordinary Shares | Award | $0 | +8,554 | +24% | $0.000000 | 44,183 | 03 Mar 2025 | Direct | F1 |
| transaction | CRH | Ordinary Shares | Tax liability | $458,747 | -4,457 | -10% | $102.93 | 39,726 | 03 Mar 2025 | Direct | F2, F3 |
| transaction | CRH | Ordinary Shares | Sale | $421,693 | -4,097 | -10% | $102.93 | 35,757 | 03 Mar 2025 | Direct | F4, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRH | Deferred Share Award | Options Exercise | $0 | -7,837 | -25% | $0.000000 | 22,916 | 03 Mar 2025 | Ordinary Shares | 7,837 | $0.000000 | Direct | F1 |
| transaction | CRH | Deferred Share Award | Award | +6,744 | +29% | 29,660 | 03 Mar 2025 | Ordinary Shares | 6,744 | $0.000000 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee"), a total of 8,554 shares vested on March 3, 2025, including the award of 717 additional Ordinary Shares as dividend equivalents. Subject to the determination of the Compensation Committee, the remaining awards of 13,389 shares and 9,527 shares are expected to vest in March 2026 and March 2027, respectively. In accordance with the DSB Plan Rules, dividend equivalents will apply to these awards and, to the extent awarded, will be reported at the time of vesting. |
| F2 | Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned award. |
| F3 | The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $ 103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request. |
| F4 | The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request. |
| F5 | Includes 128 Ordinary Shares purchased by AC Employee Benefit Trustees Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue-approved broad-based employee share participation scheme. Such Ordinary Shares are subject to a minimum holding requirement of one year. |
| F6 | Reflects a time-based conditional award, as defined in the DSB Plan Rules, of which, subject to the determination of the Compensation Committee, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting. |